FibroTouch检测肝硬度值及脂肪衰减值的稳定性分析

赵晓博; 于静; 张振华; 邹桂舟

doi:10.3969/j.issn.1001-5256.2020.01.023

FibroTouch检测肝硬度值及脂肪衰减值的稳定性分析

DOI: 10.3969/j.issn.1001-5256.2020.01.023

安徽医科大学第二附属医院肝病科

基金项目:

安徽省自然科学基金(1608085MH162)；

详细信息

中图分类号: R575.2;R575.5
计量
- 文章访问数: 1432
- HTML全文浏览量: 71
- PDF下载量: 240
- 被引次数: 0
出版历程
- 收稿日期: 2019-07-19
- 出版日期: 2020-01-20

Stability of FibroTouch in determining liver stiffness measurement and controlled attenuation parameter

Department of Hepatology,The Second Affiliated Hospital of Anhui Medical University

Research funding:

摘要

摘要: 目的探讨FibroTouch（FT）检测肝硬度值（LSM）及脂肪衰减值（CAP）的稳定性。方法选择2018年11月20日-2019年1月14日安徽医科大学第二附属医院肝病科门诊行FT检测的慢性HBV感染者（n=177）、非酒精性脂肪性肝病（NAFLD）患者（n=56）、肝功能异常患者（n=34）以及其他疾病患者（n=42）共309例,对同一受检者的3个不同测量点进行FT检测,运用组内相关系数（ICC）、Bland-Altman法评价测量值的稳定性;运用Kendall’s W检验、饼状图评价诊断结果的稳定性。结果同一受测者的3个不同测量点检测的LSM值和CAP值在不同疾病组的ICC均> 0. 75（P值均<0. 001）,其中慢性HBV感染者组的LSM值ICC最大,为0. 905;其他疾病组的CAP值的ICC最大,为0. 805;而NAFLD组的LSM值和CAP值的ICC均最小,分别为0. 785、0. 780; 3个测量点之间分别绘制Bland-Altman图,一致性限度内的点均维持在95%左右。通过分析,3个测量点的LSM分期及CAP分期的诊断结果的Kendall’s W...
- 肝硬化 /
- 脂肪肝 /
- FibroTouch
Abstract: Objective To investigate the stability of FibroTouch(FT) in the determination of liver stiffness measurement(LSM) and controlled attenuation parameter(CAP). Methods A total of 309 patients with chronic hepatitis B virus(HBV) infection,nonalcoholic fatty liver disease(NAFLD),liver function abnormalities,or other diseases who underwent FT in the outpatient service of Department of Hepatology,The Second Affiliated Hospital of Anhui Medical University,were enrolled. FT was performed at three different measurement points for the same subject,and intraclass correlation coefficient(ICC) and the Bland-Altman method were used to evaluate the stability of measured values. The Kendall's W test and pie charts were used to evaluate the stability of diagnostic results. Results LSM and CAP values of the three different measurement points for the same subject had an ICC of > 0. 75 in different disease groups(all P < 0. 001),among which the chronic HBV infection group had the highest ICC of LSM of 0. 905,the other disease group had the highest ICC of CAP of 0. 805,the NAFLD group had the lowest ICC of LSM of 0. 785 and the lowest ICC of CAP of 0. 780. The Bland-Altman plots were generated for the three measurement points,and the dots within the limits of agreement accounted for about 95%. The diagnostic results of LSM and CAP staging of the three measurement points had a Kendall's W coefficient of 0. 825 and 0. 858,respectively(all P < 0. 001). The proportion of patients with consistency between the diagnostic results for F≥2 stage(LSM > 7. 3 k Pa) and mild(or more severe) fatty liver stage(CAP >240 dB/m) based on mean value of measurement points and all three measurement points was > 60%,while the proportion of patients with consistency between the diagnostic results based on mean value of measurement points and only one measurement point was < 10%. Conclusion The values and diagnostic results of FT measurement have good stability; however,in order to improve its stability in diagnosing F ≥2 stage and mild(or more severe) fatty liver,it is suggested to use the mean value of multiple measurement points for diagnosis.
- liver cirrhosis /
- fatty liver /
- FibroTouch

HTML全文

参考文献(20)

[1] SCHMELTZER PA,TALWALKAR JA. Noninvasive tools to assess hepatic fibrosis:Ready for prime time?[J]. Gastroenterol Clin North Am,2011,40(3):507-521.

[2] KEMP W,LEVY M,WELTMAN M,et al. Australian Liver Association(ALA)expert consensus recommendations for the use of transient elastography in chronic viral hepatitis[J]. J Gastroenterol Hepatol,2015,30(3):453-462.

[3] SANDRIN L,FOURQUET B,HASQUENOPH JM,et al. Transient elastography:A new noninvasive method for assessment of hepatic fibrosis[J]. Ultrasound Med Biol,2003,29(12):1705-1713.

[4] XIAO CH,WANG WH,WANG WF,et al. Value of Fibrotouch and Fibroscan in the detection of liver tissue elastic modulus[J]. Beijing Med J,2014,36(3):202-205.(in Chinese)夏长虹，王文欢，王伟芳，等．Fibrotouch与Fibroscan检测肝脏硬度的临床效能比较[J]．北京医学，2014,36(3):202-205.

[5] CENG J,SUN WY,CHEN GY,et al. Efficiency of FibroScan and FibroTouch in liver stiffness measurement and fat quantification:A comparative analysis[J]. Chin J Hepatol,2016,24(9):652-658.(in Chinese)曾静，孙婉璐，陈光榆，等．FibroTouch与FibroScan肝脏硬度和脂肪定量检测效能的比较[J]．中华肝脏病杂志，2016,24(9):652-658.(in Chinese)

[6] Chinese Society of Hepatology and Chinese Society of Infectious Diseases Chinese,Medical Association. The guideline of prevention and treatment for chronic hepatitis B:A 2015 update[J]. J Clin Hepatol,2015,31(12):1941-1960．中华医学会肝病学分会，中华医学会感染病学分会．慢性乙型肝炎防治指南(2015年版)[J]．临床肝胆病杂志，2015,31(12):1941-1960.

[7] National Workshop on Fatty Liver and Alcoholic Liver Disease,Chinese Society of Hepatology,Chinese Medical Association;Fatty Liver Expert Committee,Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease:A 2018 update[J]. J Clin Hepatol,2018,34(5):947-957.(in Chinese)中华医学会肝病学分会脂肪肝和酒精性肝病学组，中国医师协会脂肪性肝病专家委员会．非酒精性脂肪性肝病防治指南(2018年版)[J]．临床肝胆病杂志，2018,34(5):947-957.

[8] CAO JB,CHEN YP,CHENG J,et al. Expert consensus on clinical application of transient elastic imaging(TE)(2015)[J/CD]. Chin J Liver Dis(Electr Version),2015,7(2):12-18.(in Chinese)曹建彪，陈永平，成军，等．瞬时弹性成像技术(TE)临床应用专家共识(2015年版)[J/CD]．中国肝脏病杂志(电子版)，2015,7(2):12-18.

[9] YU HM,LUO YH,SA J,et al. Intraclass correlation coefficient and software procedures[J]. Chin J Health Statistics,2011,28(5):497-500.(in Chinese)余红梅，罗艳虹，萨建，等．组内相关系数及其软件实现[J]．中国卫生统计，2011,28(5):497-500.

[10] WEN H,LU MJ. Consistency evaluation for quantitative measurements by Bland-Altman method and its clinical application[J]. J Med Postgraduates,2015,28(10):1107-1111.(in Chinese)闻浩，陆梦洁．定量测量Bland-Altman一致性评价方法研究及临床应用[J]．医学研究生学报，2015,28(10):1107-1111.

[11] LI HX,LUO Q,ZHANG R,et al. Test of Kendall coefficient of concordance W and the implementation of programs[J]. Chin J Hospital Statistics,2013,20(3):170-173.(in Chinese)李洪兴，罗庆，张荣，等．肯德尔和谐系数W检验及程序实现[J]．中国医院统计，2013,20(3):170-173.

[12] CHANG TT,LIAW YF,WU SS,et al. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B[J]. Hepatology,2010,52(3):886-893.

[13] ROCKEY DC. Fibrosis reversal after hepatitis C virus elimination[J]. Curr Opin Gastroenterol,2019,35(3):137-144.

[14] CZAJA AJ. Review article:The prevention and reversal of hepatic fibrosis in autoimmune hepatitis[J]. Aliment Pharmacol Ther,2014,39(4):385-406.

[15] DHAMIJA E,PAUL SB,KEDIA S. Non-alcoholic fatty liver disease associated with hepatocellular carcinoma:An increasing concern[J]. Indian J Med Res,2019,149(1):9-17.

[16] STARLEY BQ,CALCAGNO CJ,HARRISON SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma:A weighty connection[J]. Hepatology,2010,51(5):1820-1832.

[17] WU N,ZHANG MY,WU RH,et al. Diagnostic values of FibroScan and FibroTouch for liver fibrosis:A comparative analysis[J]. J Clin Hepatol,2014,30(7):624-627.(in Chinese)吴娜，张明媛，吴瑞红，等．FibroScan与FibroTouch对肝纤维化程度诊断价值的比较分析[J]．临床肝胆病杂志，2014,30(7):624-627.

[18] YANG XZ,GEN AW,XIAN JC,et al. Diagnostic value of various noninvasive indexes in the diagnosis of chronic hepatic fibrosis[J]. Eur Rev Med Pharmacol Sci,2018,22(2):479-485.

[19] WANG RT,TAN Q,LIU L,et al. Study on the diagnostic value of abdominal ultrasonography combined with fibrotouch in fatty liver of adolescents[J]. J Imag Res Med Appl,2019,3(9):27-28.(in Chinese)王荣桃，谭青，刘磊，等．腹部B超联合FibroTouch在青少年脂肪肝诊断价值的研究[J]．影像研究与医学应用，2019,3(9):27-28.

[20] SHEN F,ZHENG RD,SHI JP,et al. Impact of skin capsular distance on the performance of controlled attenuation parameter in patients with chronic liver disease[J]. Liver Int,2015,35(11):2392-2400.

施引文献

资源附件(0)

访问统计